![Infection Management in Patients with Sepsis and Septic Shock in Resource-Limited Settings | SpringerLink Infection Management in Patients with Sepsis and Septic Shock in Resource-Limited Settings | SpringerLink](https://media.springernature.com/lw685/springer-static/image/chp%3A10.1007%2F978-3-030-03143-5_8/MediaObjects/460168_1_En_8_Fig1_HTML.png)
Infection Management in Patients with Sepsis and Septic Shock in Resource-Limited Settings | SpringerLink
![Infection Management in Patients with Sepsis and Septic Shock in Resource-Limited Settings | SpringerLink Infection Management in Patients with Sepsis and Septic Shock in Resource-Limited Settings | SpringerLink](https://media.springernature.com/w153/springer-static/cover/book/978-3-030-03143-5.jpg)
Infection Management in Patients with Sepsis and Septic Shock in Resource-Limited Settings | SpringerLink
![Plasma from patients with bacterial sepsis or severe COVID-19 induces suppressive myeloid cell production from hematopoietic progenitors in vitro Plasma from patients with bacterial sepsis or severe COVID-19 induces suppressive myeloid cell production from hematopoietic progenitors in vitro](https://www.science.org/cms/10.1126/scitranslmed.abe9599/asset/46db1506-eb08-4052-9a81-66770c99178e/assets/graphic/abe9599-f2.jpeg)
Plasma from patients with bacterial sepsis or severe COVID-19 induces suppressive myeloid cell production from hematopoietic progenitors in vitro
![Challenges and Opportunities for Emergency Department Sepsis Screening at Triage | Scientific Reports Challenges and Opportunities for Emergency Department Sepsis Screening at Triage | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-29427-1/MediaObjects/41598_2018_29427_Fig1_HTML.png)
Challenges and Opportunities for Emergency Department Sepsis Screening at Triage | Scientific Reports
![Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019— results from a systematic review and meta-analysis | Critical Care | Full Text Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019— results from a systematic review and meta-analysis | Critical Care | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13054-020-02950-2/MediaObjects/13054_2020_2950_Fig5_HTML.png)
Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019— results from a systematic review and meta-analysis | Critical Care | Full Text
![The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020) | Journal of Intensive Care | Full Text The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020) | Journal of Intensive Care | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40560-021-00555-7/MediaObjects/40560_2021_555_Fig3_HTML.png)
The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020) | Journal of Intensive Care | Full Text
![Pre-hospital qSOFA as a predictor of sepsis and mortality - The American Journal of Emergency Medicine Pre-hospital qSOFA as a predictor of sepsis and mortality - The American Journal of Emergency Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/fc31445f-2ef9-4759-b471-3c5bd449f35d/gr1.jpg)
Pre-hospital qSOFA as a predictor of sepsis and mortality - The American Journal of Emergency Medicine
![Plasma from patients with bacterial sepsis or severe COVID-19 induces suppressive myeloid cell production from hematopoietic progenitors in vitro Plasma from patients with bacterial sepsis or severe COVID-19 induces suppressive myeloid cell production from hematopoietic progenitors in vitro](https://www.science.org/cms/10.1126/scitranslmed.abe9599/asset/3412f5e0-208c-46c7-b368-90e214045450/assets/graphic/abe9599-f1.jpeg)
Plasma from patients with bacterial sepsis or severe COVID-19 induces suppressive myeloid cell production from hematopoietic progenitors in vitro
![Sepsis Performance Improvement Programs: From Evidence Toward Clinical Implementation | Critical Care | Full Text Sepsis Performance Improvement Programs: From Evidence Toward Clinical Implementation | Critical Care | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13054-022-03917-1/MediaObjects/13054_2022_3917_Fig1_HTML.png)
Sepsis Performance Improvement Programs: From Evidence Toward Clinical Implementation | Critical Care | Full Text
![Clinical Scores and Formal Triage for Screening of Sepsis and Adverse Outcomes on Arrival in an Emergency Department All-Comer Cohort - Journal of Emergency Medicine Clinical Scores and Formal Triage for Screening of Sepsis and Adverse Outcomes on Arrival in an Emergency Department All-Comer Cohort - Journal of Emergency Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d773ac0e-9b5f-4ed0-b379-f9a51e6b6ee2/gr1_lrg.jpg)
Clinical Scores and Formal Triage for Screening of Sepsis and Adverse Outcomes on Arrival in an Emergency Department All-Comer Cohort - Journal of Emergency Medicine
![New concepts in the pathogenesis, diagnosis and treatment of bacteremia and sepsis - Journal of Infection New concepts in the pathogenesis, diagnosis and treatment of bacteremia and sepsis - Journal of Infection](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/67a0733f-4f7a-4e46-81d4-784780ef28b4/gr1_lrg.jpg)
New concepts in the pathogenesis, diagnosis and treatment of bacteremia and sepsis - Journal of Infection
![S1P lyase inhibition protects against sepsis by promoting disease tolerance via the S1P/S1PR3 axis - eBioMedicine S1P lyase inhibition protects against sepsis by promoting disease tolerance via the S1P/S1PR3 axis - eBioMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/06387b66-140b-41c2-a361-d54294b1e21b/gr1_lrg.jpg)